Featured Research

from universities, journals, and other organizations

Flu Vaccination Benefits People Of Any Age With High-risk Medical Conditions

Date:
February 22, 2005
Source:
Journal Of The American Medical Association
Summary:
Persons younger than 65 with high-risk medical conditions such as chronic lung and heart disease can substantially benefit from annual influenza vaccination during an epidemic, according to a study in the February 14 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

CHICAGO – Persons younger than 65 with high-risk medical conditions such as chronic lung and heart disease can substantially benefit from annual influenza vaccination during an epidemic, according to a study in the February 14 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Influenza continues to be a major cause of illness and death, with an annual 140,000 hospitalizations and 36,000 deaths in the United States, according to background information in the article. Many studies have shown that influenza vaccination can reduce acute respiratory disease hospitalizations and death from all causes in the elderly. This analysis, involving 75,227 patient-observations, 30,861 of which were among high-risk patients younger than 65, is the first large-scale study to show that influenza vaccination is highly effective in reducing complications across all age groups, according to the authors.

Eelko Hak, M.Sc., Ph.D., of the University Medical Center of Utrecht, the Netherlands, and his colleagues, used data from Dutch primary care data management centers during the 1999-2000 influenza A epidemic. In the Netherlands, virtually all persons recommended for influenza vaccination receive their vaccine from a general practitioner through a standardized vaccination program.

"To our knowledge, this is the first study showing high vaccine effectiveness in reducing severe end points such as deaths (78 percent) and hospitalizations for acute respiratory and cardiovascular disease (87 percent) among high-risk persons of working age," the authors stated. According to the researchers, the study is consistent with other reports that vaccination may reduce hospital admissions for cardiovascular and cerebrovascular complications as well as death or hospitalization for influenza or pneumonia in the elderly.

"…The results of our study lend strong support for the view that all high-risk persons benefit from annual influenza vaccination regardless of age," the authors conclude. "Therefore, efforts should be renewed to convince providers and patients of the clinical usefulness of such vaccination, notably among younger high-risk persons."

###

(Arch Intern Med. 2005; 165:274-280. Available post-embargo at www.archinternmed.com.)

Editor's Note: This study was financially supported by the Netherlands Health Care Insurance Board (Diemen, the Netherlands). The Netherlands Health Care Insurance Board directly subsidizes the Nethelands Progarm on Influenza. From 1997 to 2003, influenza vaccines were bought centrally from pharmaceutical industries and distributed by the Netherlands Vaccine Institute. Because no financial profits could be made by either organization, there is no conflict of interest. The design, analysis and interpretation of the study were conducted independently of the Netherlands Health Care Insurance Board.


Story Source:

The above story is based on materials provided by Journal Of The American Medical Association. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The American Medical Association. "Flu Vaccination Benefits People Of Any Age With High-risk Medical Conditions." ScienceDaily. ScienceDaily, 22 February 2005. <www.sciencedaily.com/releases/2005/02/050218132428.htm>.
Journal Of The American Medical Association. (2005, February 22). Flu Vaccination Benefits People Of Any Age With High-risk Medical Conditions. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/02/050218132428.htm
Journal Of The American Medical Association. "Flu Vaccination Benefits People Of Any Age With High-risk Medical Conditions." ScienceDaily. www.sciencedaily.com/releases/2005/02/050218132428.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins